Late Donor-Specific Antibody (Especially Class II) Development is Associated with an Increased Risk for Cardiac Allograft Vasculopathy.

被引：0
|
作者：
Kransdorf, E. [1 ]
Patel, J. [1 ]
Kittleson, M. [1 ]
Levine, R. [1 ]
Dimbil, S. [1 ]
Geft, D. [1 ]
Chang, D. [1 ]
Czer, L. [1 ]
Kobashigawa, J. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B73
引用
收藏
页码：653 / 653
页数：1
相关论文
共 50 条
  • [21] HLA-DQ C1Q BINDING DONOR SPECIFIC ANTIBODY (QDSA) ASSOCIATED WITH THE DEVELOPMENT OF CARDIAC ALLOGRAFT VASCULOPATHY (CAV)
    Lai, Chih-Hung
    Reinsmoen, Nancy L.
    Masukawa, Robin
    Ong, Geraldine
    Wang, Qi
    Naim, Mehrnoush
    Rafiei, Matthew
    Stern, Lily
    Kobashigawa, Jon A.
    HUMAN IMMUNOLOGY, 2012, 73 : 88 - 88
  • [22] Isolated Microvascular Cardiac Allograft Vasculopathy is Associated with an Increased Risk of Death or Retransplantation
    Harris, E. S.
    Sewanan, L.
    Topkara, V.
    Fried, J.
    Raikhelkar, J.
    Colombo, P.
    Yuzefpolskaya, M.
    DeFilippis, E.
    Latif, F.
    Castillo, M.
    Lam, E. Y.
    Takeda, K.
    Chernovolenko, M.
    Einstein, A.
    Johnson, L.
    Uriel, N.
    Sayer, G.
    Clerkin, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S130 - S131
  • [23] CLASS II HLA EPLET MISMATCH IS A RISK FACTOR FOR DE NOVO DONOR-SPECIFIC ANTIBODY DEVELOPMENT IN KIDNEY TRANSPLANTATION RECIPIENT
    Yamane, Hiroaki
    Tanaka, Yuka
    Ono, Kosuke
    Ohira, Masahiro
    Tahara, Hiroyuki
    Ide, Kentaro
    Ohdan, Hideki
    TRANSPLANT INTERNATIONAL, 2019, 32 : 43 - 43
  • [24] Recurrent Mild Acute Rejections and Donor-specific Antibodies as Risk Factors for Cardiac Allograft Vasculopathy in a National Pediatric Heart Transplant Cohort
    Kaskinen, Anu K.
    Tainio, Juuso
    Pihkala, Jaana I.
    Peraesaari, Juha P.
    Lauronen, Jouni
    Raissadati, Alireza
    Merenmies, Jussi M.
    Jalanko, Hannu J.
    Jahnukainen, Timo
    TRANSPLANTATION DIRECT, 2023, 9 (10): : E1534
  • [25] Circulating Donor-Specific Anti-Human Leukocyte Antigen Antibodies and Complement C4d Deposition Are Associated With the Development of Cardiac Allograft Vasculopathy
    Frank, Renee
    Molina, Maria R.
    Goldberg, Lee R.
    Wald, Joyce W.
    Kamoun, Malek
    Lal, Priti
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 142 (06) : 809 - 815
  • [26] A Specific Mechanism for Late Loss of Cardiac Allograft: The Antibody Mediated Rejection (AMR) as a Major Factor of Cardiac Allograft Vasculopathy (CAV)
    Toquet, C.
    Loupy, A.
    Rouvier, P.
    Varnous, S.
    Cazes, A.
    Tible, M.
    Beuscart, T.
    Jouven, X.
    Bruneval, P.
    Van Huyen, J. -P. Duong
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S243 - S243
  • [27] Donor-specific HLA alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation
    Tran, Andrew
    Fixler, David
    Huang, Rong
    Meza, Tiffany
    Lacelle, Chantale
    Das, Bibhuti B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (01): : 87 - 91
  • [28] The Histopathology of Lung Allograft Dysfunction Associated With the Development of Donor-specific HLA Alloantibodies
    Yousem, Samuel A.
    Zeevi, Adriana
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (07) : 987 - 992
  • [29] Donor-specific antibodies to human leukocyte antigens are associated with and precede antibodies to major histocompatibility complex class I-related chain A in antibody-mediated rejection and cardiac allograft vasculopathy after human cardiac transplantation
    Nath, Dilip S.
    Angaswamy, Nataraju
    Basha, Haseeb Ilias
    Phelan, Donna
    Moazami, Nader
    Ewald, Gregory A.
    Mohanakumar, T.
    HUMAN IMMUNOLOGY, 2010, 71 (12) : 1191 - 1196
  • [30] Higher Donor Body Mass Index Is Associated with Higher Risk of Cardiac Allograft Vasculopathy
    Khalife, W. I.
    Vivo, R. P.
    Nalabothu, P.
    Garikipati, S.
    Johnson, S.
    Kislingbury, K.
    Sharif, R.
    Charif, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S211 - S211
12345